Ketamine therapy has become known for its effects at combating depression and other mood disorders. There’s a growing body of ...

A new study has found small amounts of liquid ketamine administered in a clinical setting can significantly reduce symptoms ...

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

Because it is still awaiting approval, Medicare does not typically cover the use of ketamine infusion for treating mental ...

CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

A ketamine-based nasal spray is officially the first and only standalone therapy available for treatment-resistant depression ...

The US FDA has approved the first of its kind ketamine-based nasal spray which is supposed to act as a standalone therapy for ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

A new UniSC study has found small amounts of liquid ketamine administered in a clinical setting can significantly reduce symptoms of post-traumatic ...

Why We Need Fast-Acting Anxiety Relief Now More Than Ever Anxiety isn’t just feeling nervous before a big event—it can be relentless, overwhelming, and even debilitating. Traditional treatments like ...

Exploring new treatment avenues has become crucial as mental health challenges such as depression and PTSD continue impacting ...

FDA approves esketamine nasal spray as a standalone treatment for adults with treatment-resistant depression, offering rapid ...